Advertisement
The Company will also conduct a teleconference and live audio webcasthosted by Palatin's executive management team on February 11, 2008 at whichthey will discuss the results of operations in greater detail and provide anupdate on corporate developments.
Advertisement
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company focused ondiscovering and developing targeted, receptor-specific small molecule andpeptide therapeutics. The Company's internal research and developmentcapabilities, anchored by its proprietary MIDAS(TM) technology, are fuelingproduct development. Palatin's strategy is to develop products and then formmarketing collaborations with industry leaders in order to maximize theircommercial potential. The Company currently has collaborations withAstraZeneca and the Mallinckrodt division of Covidien. For additionalinformation regarding Palatin, please visit Palatin Technologies' website athttp://www.palatin.com.Schedule for the Financial Results Press Release, Conference Call and Webcast
SOURCE Palatin Technologies, Inc.